2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Rating of “Moderate Buy” from Analysts
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, four have given a buy rating and one […]
More Stories
The Future of AI in Entertainment: How AI Is Changing Online Casinos, Gaming, and Streaming
The entertainment sector is quickly changing with the integration of Artificial Intelligence (AI) by more and more companies – from...
J Heath Deneke Sells 1,000 Shares of Summit Midstream Corporation (NYSE:SMC) Stock
Summit Midstream Corporation (NYSE:SMC – Get Free Report) CEO J Heath Deneke sold 1,000 shares of the firm’s stock in...
Incyte Co. (NASDAQ:INCY) Receives Average Rating of “Hold” from Brokerages
Incyte Co. (NASDAQ:INCY – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty ratings firms...
Eaton Co. plc (NYSE:ETN) Receives Average Rating of “Moderate Buy” from Brokerages
Eaton Co. plc (NYSE:ETN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen...
NextEra Energy Partners, LP (NYSE:NEP) Given Consensus Recommendation of “Hold” by Analysts
NextEra Energy Partners, LP (NYSE:NEP – Get Free Report) has received a consensus rating of “Hold” from the seventeen analysts...
Analysts Set First Solar, Inc. (NASDAQ:FSLR) Target Price at $279.04
Shares of First Solar, Inc. (NASDAQ:FSLR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...